Abstract:Background: Obesity is characterized by an increase of adipose tissue, already acknowledged as an endocrine tissue organ. A maze of cytokines, hormones, substrates, and products regulate at short and long-term hunger and satiety through signals from the gastrointestinal tract and adipose tissue. Objective: To compare the mid- and long-term effect of two Mediterranean diet (MedD) interventions with the aim of weight loss or not on peripheral satiety-related hormones, weight loss, glucose and lipid metabolism, and pro-inflammatory markers in obese/overweight subjects with metabolic Methods: A randomized lifestyle intervention, with a large cohort of patients presenting metabolic syndrome. Participants were overweight/obese men and women, who at baseline met at least three metabolic syndrome components. Subjects were assigned to two intervention groups: 1) an intensive life-style intervention with an energy-reduced MedD and physical activity promotion (Intervention Group) with the aim of losing weight, and 2) a normocaloric MedD (Control Group). In the subsample of participants from Hospital del Mar Research Institute (Barcelona), we quantified in a subsample at baseline, 6 months, and 1 year the following analytes: glucose, HbA1c, triglycerides, total cholesterol, high-density lipoprotein cholesterol and LDL cholesterol, C-peptide, ghrelin, GLP-1, glucagon, insulin, leptin, PAI-1, resistin and visfatin. Multivariate analysis and linear mixed-effects models were performed to compare changes in risk factors and biomarkers between intervention groups and over time. Results: Compared to participants in the control group, those in the intervention group showed greater improvements in weight and waist circumference, insulin (P<0.001), glucose metabolism-related compounds (P<0.05), triglyceride-related lipid profile (P<0.05), leptin, blood pressure, and pro-inflammatory markers such as PAI-1 (P<0.001) versus the control group at mid- or/and long-term. Those markers, high-sensitivity C reactive protein, resistin, and vifastin also decreased in both intervention groups. Weight change, regardless of the intervention group, was directly related with an increase in HDL cholesterol and a decrease in LDL cholesterol, systolic and diastolic blood pressure, HbA1c, glucagon, and PAI-1 (P<0.05). Conclusion: An intervention with the aim of weight loss using a hypocaloric MedD and physical activity promotion has beneficial effects on adiposity, glucose metabolism, lipid profile, leptin, and pro-inflammatory markers such as PAI-1 at mid- and long-term.

Effects of a Two-Year Lifestyle Intervention on Intrahepatic Fat Reduction and Renal Health: Mitigation of Inflammation and Oxidative Stress, a Randomized Trial

Energy Expenditure Improved Risk Factors Associated with Renal Function Loss in NAFLD and MetS Patients

A Greater Improvement of Intrahepatic Fat Contents after 6 Months of Lifestyle Intervention Is Related to a Better Oxidative Stress and Inflammatory Status in Non-Alcoholic Fatty Liver Disease

Long-Term Impact of Nutritional Intervention with Increased Polyphenol Intake and Physical Activity Promotion on Oxidative and Inflammatory Profiles in Patients with Metabolic Syndrome

Impact of a Mediterranean diet on hepatic and metabolic outcomes in non‐alcoholic fatty liver disease: The MEDINA randomised controlled trial

Effect of 1-year lifestyle intervention with energy-reduced Mediterranean diet and physical activity promotion on the gut metabolome and microbiota: a randomized clinical trial

Mid- and long-term changes in satiety-related hormones, lipid and glucose metabolism, and inflammation after a Mediterranean diet intervention with the goal of losing weight: A randomized, clinical trial

Effect of a lifestyle intervention program with energy-restricted Mediterranean diet and exercise on the serum polyamine metabolome in individuals at high cardiovascular disease risk: a randomized clinical trial

Adherence to the Mediterranean diet and nuclear magnetic resonance spectroscopy biomarkers in older individuals at high cardiovascular disease risk: cross-sectional and longitudinal analyses

Effects of Mediterranean Diet on Endothelial Reactivity in Individuals with High Cardiometabolic Risk: A Randomized Controlled Parallel-Group Preliminary Trial

Mediterranean Personalized Diet Combined with Physical Activity Therapy for the Prevention of Cardiovascular Diseases in Italian Women

Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake

The effects of dietary intervention on fibrosis and biochemical parameters in metabolic-associated fatty liver disease

Effectiveness of a multiple health-behaviour-change intervention in increasing adherence to the Mediterranean Diet in adults (EIRA study): a randomized controlled hybrid trial

Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial

Protective Effect of High Adherence to Mediterranean Diet on the Risk of Incident Type-2 Diabetes in Subjects with MAFLD: The Di@bet.es Study

Effect of 5:2 intermittent fasting diet versus daily calorie restriction eating on metabolic-associated fatty liver disease-a randomized controlled trial

Effect on gut microbiota of a 1-y lifestyle intervention with Mediterranean diet compared with energy-reduced Mediterranean diet and physical activity promotion: PREDIMED-Plus Study

A Low Glycemic Index Mediterranean Diet Combined with Aerobic Physical Activity Rearranges the Gut Microbiota Signature in NAFLD Patients

Healthy Lifestyle Changes Improve Cortisol Levels and Liver Steatosis in MASLD Patients: Results from a Randomized Clinical Trial

Effectiveness of A Multifactorial Intervention in Increasing Adherence to the Mediterranean Diet among Patients with Diabetes Mellitus Type 2: A Controlled and Randomized Study (EMID Study)